原发性胃肠道非何杰金淋巴瘤——附142例报道  

PRIMARY CASTRO-INTESTINAL NON-HODGKIN'S LYMPHOMA——A study of 142 cases

作　　者：施学辉[1] 王颖[1] 吴根娣[1] 刘新伟[1] 张志义 

机构地区：[1]上海医科大学肿瘤医院

出　　处：《中华放射肿瘤学杂志》1991年第1期4-7,共4页Chinese Journal of Radiation Oncology

摘　　要：本文分析1970年至1986年间我院收治的原发性胃肠道非何杰金淋巴瘤142例,着重讨论影响预后的因素,探求最佳治疗方案。 材料与方法 本组病例全部经剖腹探查及病理检查证实,临床分期采用Ann Arbor分期,病理分类以1982年全国淋巴瘤分类法并参照WHO及我院分类法进行分类。 原发部位:胃55例,小肠18例,回盲部58例,One hundred and forty-two patients with primary gastro-intestinal non-Hodgkin's lymphoma were treated at our hospital 1970-1986. The primary sites were. 55 stomach, 18 small bowel, 58 ileocecal region and 11 large bowel. All patients had laparotomy for diagnosis and/or management. In 96 complete resection, 35 incomplete resection was done and 10 were unresectable. 68 patients received postoperative radiotherapy, 56 received postoperative radiotherapy plus chemotherapy, 7 received chemotherapy only after surgery and 11 patients were treated by surgery only. The 3-year survival rates for patients with stomach, ileocecal, small bowel and large bowel primary non-Hodgk-in' s lymphoma were 74.5% ,70.7%, 44.4% and 45.5% respectively. The important prognostic factors were, the site of primary tumor, the depth of invasion- stage and the mode of management. Sex, age and histologic type were irrelevant. Adequate initial surgery combined with postoperative radiotherapy for patients with complete resectable Stage IE and HE lesions and postoperative radiotherapy pins adequate chemotherapy for more than 6 months for patients with incomplete resection or unresectable Stage IE and HE disease could be considered adequate.

关 键 词：非何杰金淋巴瘤 原发部位 最佳治疗方案 病理检查 ARBOR 临床分期 病理分类 多野照射 术后放疗 小野 

分 类 号：R73[医药卫生—肿瘤]